Clinical Trial Update: MEPHISTO (Macrophage Phenotype In Metabolic Syndrome With Iron Overload)

View source ↗

Summary

Update on the MEPHISTO trial (NCT02066012) assessing macrophage phenotype in metabolic syndrome with iron overload, sponsored by University Hospital in Clermont…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload
• Metabolic Syndrome

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Dysmetabolic Iron Overload Syndrome, Metabolic Syndrome X | Status: UNKNOWN